More on QGEN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $43.86 |
|
|||
| Open | $43.19 | ||||
| 52 Wk High | $28.50 | ||||
| 52 Wk Low | $19.94 | ||||
| Day High | $43.66 | ||||
| Day Low | $42.79 | ||||
| P/E | 149.90 | ||||
| EPS | $0.29 | ||||
| Volume | 1,922,422 | ||||
- Jury finds Parse Biosciences willfully infringed 10x Genomics patents
- 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
- QIAGEN launches QIAsymphony Connect nucleic acid extraction platform
- QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction
- Qiagen names Jonathan Pratt as CEO amid takeover talks
- Qiagen names Jonathan Pratt as CEO, replacing Thierry Bernard
- QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
- Qiagen (QGEN) Halted, News Pending
- EQT And KKKR Said Among Firms Considering Bids For Qiagen - Bloomberg
- FDA clears Qiagen bloodstream infection panel for U.S. market
Entities mentioned with QGEN
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Stock Buyback | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
